Boston Scientific (BSX) weekly implied volatility at 51 into Q2
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Boston Scientific (BSX) PT Raised to $32 at Cowen
July 27, 2017 3:50 PM EDTCowen raised its price target on Boston Scientific (NYSE: BSX) to $32.00 (from $31.00) while maintaining a Outperform rating.
Management revised full year 2017 guidance and effectively kept the midpoint of the organic revenue guidance range intact at 5.8% while raising the EPS target by $0.01.
... MoreStifel Reiterates Buy on Boston Scientific (BSX) Following 2Q
July 27, 2017 1:41 PM EDTStifel reiterated a Buy rating and $32.00 price target on Boston Scientific (NYSE: BSX) following the company's 2Q. Revenue at $2.257 billion grew 6% reported and on organic basis, and 7% on an operational basis. BSX modestly raised the top-end of its previous 2017 organic sales growth... More
